Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Xylazine

Related Products

Hot Products

Basic Information Post buying leads Suppliers
This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
Name

Xylazine

EINECS 230-902-1
CAS No. 7361-61-7 Density 1.15 g/cm3
PSA 49.69000 LogP 2.71680
Solubility N/A Melting Point 140 °C
Formula C12H16N2S Boiling Point 334.2 °C at 760 mmHg
Molecular Weight 220.338 Flash Point 155.9 °C
Transport Information N/A Appearance N/A
Safety 45-37/39-26 Risk Codes 25-36/37/38
Molecular Structure Molecular Structure of 7361-61-7 (Xylazine) Hazard Symbols ToxicT,IrritantXi
Synonyms

4H-1,3-Thiazine,5,6-dihydro-2-(2,6-xylidino)- (7CI,8CI);2-(2,6-Dimethylphenylamino)-5,6-dihydro-4H-1,3-thiazine;Anased;BAY 1470;Primazine;Sedomin;Wh 7286;Xylazine;

 

Xylazine Synthetic route

1-(2,6-dimethylphenyl)-3-(3-propanol)thiourea

7361-61-7

xylazine

Conditions
ConditionsYield
With hydrogenchloride In water at 80 - 95℃; Industrial scale;95%
87-62-7

2,6-dimethylaniline

7361-61-7

xylazine

Conditions
ConditionsYield
With acetic anhydride In tetrahydrofuran; ethanol113.8 g (84%)
tetrahydrofuran ("THF")

tetrahydrofuran ("THF")

19241-16-8

2,6-dimethylphenylisothiocyanate

156-87-6

propan-1-ol-3-amine

7361-61-7

xylazine

Conditions
ConditionsYield
With hydrogenchloride; sodium hydroxide In water; acetone
19241-16-8

2,6-dimethylphenylisothiocyanate

156-87-6

propan-1-ol-3-amine

7361-61-7

xylazine

Conditions
ConditionsYield
With hydrogenchloride In water16.3 g (80%)
2198-53-0

N-(2,6-dimethylphenyl)acetamide

7361-61-7

xylazine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium hydride / tetrahydrofuran; toluene / 0.5 h / Industrial scale
2: 50 - 80 °C / Industrial scale
3: hydrogenchloride / water / 80 - 95 °C / Industrial scale
View Scheme
1336-21-6

ammonium hydroxide

541-41-3

chloroformic acid ethyl ester

7361-61-7

xylazine

67-63-0

isopropyl alcohol

87-62-7

2,6-dimethylaniline

19241-16-8

2,6-dimethylphenylisothiocyanate

Conditions
ConditionsYield
With carbon disulfide In propan-1-ol; water55.2%
2873-74-7

gloutaric dichloride

7361-61-7

xylazine

C17H21ClN2O2S

Conditions
ConditionsYield
With triethylamine at 4℃;
98-88-4

benzoyl chloride

7361-61-7

xylazine

29280-54-4

N-(5,6-dihydro-4H-[1,3]thiazin-2-yl)-N-(2,6-dimethyl-phenyl)-benzamide

Conditions
ConditionsYield
With pyridine
100-07-2

4-methoxy-benzoyl chloride

7361-61-7

xylazine

29280-56-6

N-(5,6-dihydro-4H-[1,3]thiazin-2-yl)-N-(2,6-dimethyl-phenyl)-4-methoxy-benzamide

Conditions
ConditionsYield
With pyridine
933-88-0

ortho-toluoyl chloride

7361-61-7

xylazine

29280-58-8

N-(5,6-dihydro-4H-[1,3]thiazin-2-yl)-N-(2,6-dimethyl-phenyl)-2-methyl-benzamide

Conditions
ConditionsYield
With pyridine

Xylazine Specification

The Xylazine is an organic compound with the formula C12H16N2S. The IUPAC name of this chemical is N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine. With the CAS registry number 7361-61-7, it is also named as 4H-1,3-thiazin-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro-. The product's classification codes are Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-agonists; Drug / Therapeutic Agent; Human Data; Neurotransmitter Agents. Xylazine is a drug that is used for sedation, anesthesia, muscle relaxation, and analgesia in animals such as horses, cattle and other non-human mammals

Physical properties about Xylazine are: (1)ACD/LogP: 2.71; (2)ACD/LogD (pH 5.5): 0.93; (3)ACD/LogD (pH 7.4): 2.26; (4)ACD/BCF (pH 5.5): 1.13; (5)ACD/BCF (pH 7.4): 24.04; (6)ACD/KOC (pH 5.5): 11.82; (7)ACD/KOC (pH 7.4): 252.72; (8)#H bond acceptors: 2; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 1; (11)Index of Refraction: 1.611; (12)Molar Refractivity: 66.298 cm3; (13)Molar Volume: 190.932 cm3; (14)Polarizability: 26.282 10-24cm3; (15)Surface Tension: 40.6339988708496 dyne/cm; (16)Density: 1.154 g/cm3; (17)Flash Point: 155.944 °C; (18)Enthalpy of Vaporization: 57.718 kJ/mol; (19)Boiling Point: 334.241 °C at 760 mmHg

Uses of Xylazine: In veterinary anesthesia, Xylazine is often used in combination with ketamine. It is a drug that is used for anesthesia, sedation, muscle relaxation, and analgesia in animals such as horses, cattle and other non-human mammals. As with other α2 agonists, adverse effects include bradycardia, conduction disturbances and myocardial depression. As an emetic, it is desirable to remove a substance from a cat's stomach.

When you are using this chemical, please be cautious about it as the following:
It is toxic if swallowed. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Besides, this chemical is irritating to eyes, respiratory system and skin. When you are using it, wear suitable gloves and eye/face protection. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).

You can still convert the following datas into molecular structure:
(1)InChI=1S/C12H16N2S/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12/h3,5-6H,4,7-8H2,1-2H3,(H,13,14);
(2)InChIKey=BPICBUSOMSTKRF-UHFFFAOYSA-N;
(3)Smilesc1(NC2=NCCCS2)c(cccc1C)CThe toxicity data is as follows:

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 18mg/kg (18mg/kg)   U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#10054,
mouse LD50 oral 240mg/kg (240mg/kg)   Deutsche Tieraerztliche Wochenschrift. Vol. 75, Pg. 565, 1968.
 
mouse LD50 subcutaneous 121mg/kg (121mg/kg)   Deutsche Tieraerztliche Wochenschrift. Vol. 75, Pg. 565, 1968.
 
rat LD50 oral 130mg/kg (130mg/kg)   Deutsche Tieraerztliche Wochenschrift. Vol. 75, Pg. 565, 1968.
 
women TDLo intramuscular 734ug/kg (.734mg/kg) SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE

CARDIAC: PULSE RATE 

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
American Journal of Emergency Medicine. Vol. 4, Pg. 222, 1986.
 
women TDLo intramuscular 22mg/kg (22mg/kg) LUNGS, THORAX, OR RESPIRATION: PLEURAL THICKENING

CARDIAC: PULSE RATE 

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
American Journal of Emergency Medicine. Vol. 4, Pg. 222, 1986.
 
women TDLo oral 8mg/kg (8mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

CARDIAC: PULSE RATE
Clinical Toxicology. Vol. 18, Pg. 663, 1981.